Key Drivers
- Profitability Strength
- Q1 Deterioration
- Balance Sheet Risk
AIAI Summary
USPH should be viewed less as a steady healthcare operator and more as an acquisition-led compounder whose upside now depends on disciplined, accretive deals and sustained margin/cash conversion, because the recent quarter showed leverage and free-cash-flow volatility can quickly pressure the thesis even as the stock runs ahead of fundamentals.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Profitability Strength
- •Q1 Deterioration
- •Balance Sheet Risk
USPH finished fiscal 2025 with solid profitability and strong free cash flow, but Q1 2026 showed weaker margins, negative free cash flow, higher leverage, and a valuation that looks expensive rather than cheap.
Price Behavior
Key Price Behavior Insights:
- •Higher highs
- •Breakout follow-through
- •Overbought risk
USPH remains in a strong uptrend after breaking above the high-$68 resistance and closing at its last-month high, but the rapid late-June advance and volatility argue for caution on new entries until upper-$60s support is confirmed.
Sharp mid-June drop followed by a fast late-June surge points to elevated short-term volatility risk
Sentiment & News
Key News Insights:
- •Network growth
- •Revenue lift
- •Acquisition-led
U.S. Physical Therapy expanded its outpatient network by acquiring a 12-clinic practice with a 67% stake, adding about 112,000 annual visits and $12 million in revenue.
This acquisition should modestly strengthen USPH's scale and earnings base while reinforcing its growth-through-buyouts strategy
Similar Companies in Healthcare
Other companies in the same sector with AI ratings